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The Barcelona Brain Health Initiative (BBHI) is an ongoing prospective longitudinal
study focused on identifying determinants of brain health. The main objectives are: (i)
to characterize lifestyle, cognitive, behavioral and environmental markers related to a
given individual’s cognitive and mental functions in middle to old age, (ii) to assess the
biological determinants predictive of maintenance of brain health, and (iii) to evaluate
the impact of a controlled multi-dimensional lifestyle intervention on improving and
maintaining brain health. The BBHI cohort consists of >4500 healthy participants aged
40–65 years followed through online questionnaires (Phase I) assessing participants’
self-perceived health and lifestyle factors in seven different domains: overall health,
physical exercise, cognitive activity, sleep, nutrition, social interactions, and life
purpose. In Phase II a sub-group of 1,000 individuals is undergoing detailed in-
person evaluations repeated at two-yearly intervals. These evaluations will provide
deep phenotyping of brain function, including medical, neurological and psychiatric
examinations, assessment of physical fitness, neuropsychological assessments,
structural and functional brain magnetic resonance imaging, electroencephalography
and perturbation-based non-invasive brain stimulation evaluations of brain activity,
as well as collection of biological samples. Finally, in Phase III a further sub-group
of 500 participants will undergo a similar in-person assessment before and after a
multi-dimensional intervention to optimize lifestyle habits and evaluate its effects on
cognitive and brain structure and function. The intervention group will receive remote
supervision through an ICT-based solution, with the support of an expert in health and
lifestyle coaching strategies aimed at promoting adherence. On the other hand, the
control group will not have this coaching support, and will only receive education and
recommendations about healthy habits. Results of this three-part initiative shall critically
contribute to a better understanding of the determinants to promote and maintain brain
health over the lifespan.
Keywords: brain health, lifestyles, cognitive reserve, multi-dimensional, intervention, cognitive enhancement,
cohort study
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INTRODUCTION
Human life expectancy has significantly increased in recent
decades thanks to the advances in public health and medicine.
In the developed world the number of older adults (>65 years)
has already surpassed the number of children (<15 years), and
by 2050 the proportion of elderly people is projected to nearly
double that of the young (United Nations, 2017). However, the
extension of lifespan does not correlate well with the extension of
a healthy lifespan (or health-span; Passarino et al., 2016).
Advancing age is the major risk factor for the development
of neurological and psychiatric brain disorders, and aging
is associated with increased prevalence of conditions
such as epilepsy, stroke, and major neuropsychiatric or
neurodegenerative diseases (Barnett et al., 2012). Epidemiologic
data collected in recent decades indicate the strong need to focus
research efforts on the prevention of these disorders, given that
their prevalence is greater than that of cardiovascular diseases
and cancer, representing 13% of the global burden of diseases
(Collins et al., 2011). In Europe each year almost 40% of the
population suffers from at least one disorder pertaining to the
neuropsychiatric spectrum (Wittchen et al., 2011), and according
to World Health Organization (WHO) estimations, by 2030, half
of the world-wide economic impact of disability will be due to
brain related disability (as measured by disability-adjusted life
year, DALY; Mathers and Loncar, 2006).
Brain Health is defined as the development and preservation
of optimal brain integrity and neural network functioning for
a given age (Gorelick et al., 2017). Maintaining brain health
across the lifespan is likely linked to preservation of efficient
mechanisms of plasticity, i.e., the nervous systems’ ability to
make rapid adaptations to changeable internal and external
environmental demands (Pascual-Leone, 2006). The mechanisms
of plasticity evolve over the lifespan but remain responsive
to changing environmental factors even at advanced ages.
Alterations in the mechanisms of plasticity are related to the
development of disease or disability (Pascual-Leone et al., 2011).
However, impaired efficacy, and a resulting loss in brain health,
does not appear to be an obligatory consequence of aging
(Pascual-Leone et al., 2011).
Longitudinal studies tracking brain health metrics, such as
general cognitive (Yaffe et al., 2009) and memory performance
(Josefsson et al., 2012), suggest three main trajectories of
cognitive aging: (1) individuals who exhibit significant cognitive
decline over time; (2) individuals who show cognitive decline
yet remain within an age-appropriate range; and finally (3)
individuals who maintain cognitive performance and experience
little cognitive decline even at advanced age. Similarly, some
individuals show steep decrements of the efficacy of the
mechanisms of plasticity over time, whilst others do not (Pascual-
Leone et al., 2011; Freitas et al., 2013). Theoretical models such as
‘cognitive or brain reserve’ (Stern, 2009) or ‘brain maintenance’
(Nyberg et al., 2012) have been put forward to better understand
the individual characteristics and underlying brain mechanisms
associated with preservation of cognition and brain function in
the face of advancing age or even the initial stages of pathology.
Beyond theoretical models, neuroimaging studies have stressed
that the preservation of cognitive and mental health is associated
with either the maintenance of brain structure, activity or
connectivity patterns with advancing age (Nyberg et al., 2012),
and/or with the expression of compensatory responses in the
face of pathological changes (Stern, 2012; Elman et al., 2014;
Reuter-Lorenz and Park, 2014).
In recent years a major focus has been placed on the
discovery and validation of new ‘biomarkers’ for major diseases
(Olsson et al., 2016 for a recent review and meta-analysis)
that allow the identification of ‘at risk’ individuals, or even
subjects at ‘preclinical stages’ of diseases, years before the possible
manifestation of clinical symptoms (e.g., Dubois et al., 2007).
It is now well-accepted that structural and functional brain
changes associated with the development of neurodegenerative
diseases can begin some 10–20 years prior to the onset of
symptoms (Beason-Held et al., 2013). During this “pre-clinical
period,” individual differences in brain resilience may delay the
appearance of symptoms or act to reduce or eliminate the
clinical and behavioral impact of pathologies (Nyberg et al.,
2012). For this reason, there is a strong need to focus research
on such factors that could prevent illness and promote brain
resilience in the presence of pathology. For example, in the case
of dementia, delaying the onset of symptoms for just 1 year could
prevent disability in over 11.8 million cases in the next 30 years
representing a cost savings of $219 billion (Brookmeyer et al.,
2007; Zissimopoulos et al., 2015).
Modifiable Lifestyle Factors and Their
Interactions With Biological Markers
Recently it has been proposed that experience-based changes in
brain structure and function may act, in aging, as protective
factors that contribute to intra-individual differences in the
resilience to brain pathologies (Gelfo et al., 2017). Thus it has
been suggested that specific modifiable health and lifestyle factors
have the potential to prevent and delay the onset of dementia
and improve coping or recovery from injuries or illnesses (see
Figure 1; Di Marco et al., 2014; Frankish and Horton, 2017;
Livingston et al., 2017). It has been estimated that several
modifiable risk factors, such as physical activity, socialization,
weight and blood pressure control, psychological well-being and
cognitive activity across the lifespan could prevent more than
30% of the diagnosed cases of dementia (Livingston et al., 2017).
Similarly, it has been proposed that specific dietary patterns (e.g.,
Mediterranean diet; Guasch-Ferré et al., 2017, see Loughrey et al.,
2017 for a review) good sleep quality (Sexton et al., 2014; Fung
et al., 2016), and definition of a clear purpose in life (Ryff et al.,
2016; Wilson and Bennett, 2017) have a positive effect on brain
health in aging and may reduce the incidence of brain diseases.
Lifestyles have been shown to interact with biomarkers and
have the potential to promote mechanisms of brain resilience
(Landau et al., 2012; Wirth et al., 2014; Arenaza-Urquijo et al.,
2015). For example, exposure to enriched cognitive environments
at a given age may promote maintenance of cognitive function
and attenuation of Aβ amyloid deposition among apolipoprotein
(APOE) ε4 allele carriers (Vemuri et al., 2014). Similarly, physical
activity and adherence to the Mediterranean diet has been shown
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FIGURE 1 | Schematic representation of disease progression and the time frame in which modifiable lifestyles could prevent disease onset or promote brain
resilience (see Arenaza-Urquijo and Vemuri, 2018 about the differences between these two terms). The B brain images illustrate where the objectives and
hypotheses of the BBHI aim to have the most impact.
to attenuate the burden of disease in Alzheimer’s disease (AD)
(Matthews et al., 2014), as well as sustain brain structure and
cognitive function in older adults (Kramer and Erickson, 2007).
Beyond an association between lifestyle factors and brain
health, the potentiation of certain brain health metrics has been
evidenced via dedicated interventions. For example, dedicated
physical exercise programs have been shown to preserve neural
networks associated with cognitive decline (Voss et al., 2016),
and dietary interventions (high antioxidant rich foods associated
with the Mediterranean diet as well as walnuts) have been
shown to improve cognitive function (Valls-Pedret et al., 2015).
Consequently, the potential to modify such lifestyle habits
associated with brain health exists and may lead to the promotion
and modification of brain health across the lifespan (Ngandu
et al., 2015; Rosenberg et al., 2018).
However, there remains a significant knowledge gap
precluding the personalized prescription of specific lifestyle
modifications to promote an individual’s brain resilience and
reduce the incidence of major neuropsychiatric and neurological
diseases. The Barcelona Brain Health Initiative (BBHI) seeks to
fill these knowledge gaps.
The Barcelona Brain Health Initiative:
Rationale
The BBHI is a longitudinal prospective cohort study with
the primary aim to examine, characterize and promote the
lifestyle factors, biological determinants and their interactions
that permit certain individuals to avoid the development
or clinical manifestation of major neuropsychiatric and
neurodegenerative disorders. The main objectives of the
BBHI are (i) to characterize lifestyle, cognitive, behavioral
and environmental markers associated with good cognitive
and mental functions in middle to old age, (ii) to assess
the biological determinants predictive of the maintenance
of brain health and prevention of neuropsychiatric illnesses
over aging, and (iii) to evaluate the effect of a controlled




The BBHI consists of three phases: In Phase I volunteers are
engaged through the creation of a personal profile in a dedicated
web-based platform1, and periodically asked to respond to on-
line questionnaires and surveys. Frequent email contact, social
media interactions and in-person meetings with selected groups
of participants help keep the cohort engaged and offer important
educational value on lessons learned regarding factors that
promote and sustain brain health. In Phase II, a sample of
1,000 participants is undergoing a detailed clinical phenotyping
through a multi-day in-person evaluation that includes cognitive,
physical and medical assessments, biological sample recollection,
structural and functional magnetic resonance imaging (MRI),
electroencephalography (EEG) and perturbation biomarkers
with transcranial magnetic stimulation (TMS) combined with
EEG. A critical component of this phase II is the longitudinal,
biannually repeated evaluation to identify biologic correlates
of subjective and behavioral changes. Finally, in Phase III,
a sample of 500 participants will undergo a controlled non-
pharmacological clinical trial to evaluate the impact of a multi-
dimensional intervention designed to improve metrics of brain
health including psychological, medical and biological indicators.
BBHI Cohort
BBHI Launching and Recruiting
A comprehensive communication campaign was designed and
implemented to publicize the project and recruit participants.
After a kick-off press conference, the BBHI project was covered
in both local and national media with more than 10 interviews
on the mainstream radio and TV programs. The project’s public
and private website, as well as social media (Facebook and Twitter
accounts), were developed and continue to increase their reach
monthly. Furthermore, over 15 large companies were contacted
to raise their interest and encourage their workers to register
1https://bbhi.cat
Frontiers in Aging Neuroscience | www.frontiersin.org 3 October 2018 | Volume 10 | Article 321
fnagi-10-00321 October 11, 2018 Time: 16:40 # 4
Cattaneo et al. The Barcelona Brain Health Initiative
and participate in the project, through conferences and internal
communication channels. Conferences for the general public are
regularly held in different forums for information as well as
recruitment purposes.
In addition, an Ambassador program involving public opinion
leaders in the age range of the study participants helps spread
the values promoted by the project (healthy diet, physical fitness,
etc.). Several well-known personalities from sport, culture and
nutrition have participated as BBHI ambassadors through videos
of support for the project and media events. Furthermore,
testimonies from volunteers have been also recorded, aiming to
create a sense of proximity to the target population of the study.
The BBHI Community
Beyond the study cohort, and in an effort to more broadly
educate the public on determinants of brain health and establish
stable platforms to share and disseminate meaningful results, we
established the BBHI community. The BBHI community includes
the cohort of participants that have signed up to the study via the
online web-based platform or mobile application, but also anyone
interested in the topic or linked, directly or indirectly, to the BBHI
team. In addition to regular communication via social media,
periodic public conferences are organized. Through the BBHI
community, we disseminate information on recent findings and
scientific breakthroughs on the benefits of healthy lifestyle habits,
trying to convert validated scientific evidence into brain health-
promoting recommendations. Thus the BBHI invests effort into
social responsibility. Furthermore, through larger events – such
as sports or culinary celebrations – we seek to promote a sense of
belonging and stake-holder engagement.
As an important component of the BBHI community, active
involvement of the volunteers in the study has been ensured
through the designation of a “reference group” of volunteers,
representative of the wider cohort, who are periodically invited
to face to face meetings with the BBHI research and leadership
team. Feedback from the BBHI community is thus an integral
contributor to study protocols and procedures.
Characterization of the Cohort
Barcelona Brain Health Initiative study participants are
community-dwelling individuals between 40 and 65 years of
age, of both sexes, free from any self-reported neurological or
psychiatric diagnosis at the time of recruitment. As of the end
of June 2018, 4,757 participants have enrolled in the project
via the web-based application and completed the first on–line
questionnaire. Of these, 189 subjects were excluded because
they reported to be less than 40 years old or older than 65 years.
Another 362 subjects reported to have been diagnosed with
neurologic or psychiatric disease, including Alzheimer’s disease,
Parkinson’s disease, multiple sclerosis, amyotrophic lateral
sclerosis, cerebral stroke, schizophrenia, or major depression.
Accordingly, 4,206 participants (2,792 women) are active
participants in the study to date. Mean age ± standard deviation
of the participants is 52 ± 7 years with an age distribution
that is highly representative of the Catalan population. The
cohort does, however, include an over-representation of women
(66%), and participants have overall a higher education level
than the general population (70% have advanced studies,
bachelor degree equivalent or higher). The socio-demographic
information of currently enrolled participants is summarized in
Table 1.
Phase 1: Self-Report Online
Questionnaires
All procedures were approved by the ethics and research
institutional review board of the Institut Guttmann. Phase I
has been designed completely online. Each participant registers
in the study through the website of the project2, by filling
out an initial form. This creates a personal account on the
private website of the project3, associated to their personal
email address. At the first login, after setting a password,
participants are prompted with a web-based consent form,
explaining the aims of the study, consequences and benefits
of participating in this Phase I of the study. Enrollment
in the study is completed only after accepting this consent.
Subsequently participants can access a personal profile page,
where the online questionnaires are available to be completed (see
Figure 2).
Upon recruitment to the study, and provision of the web-
based informed consent, participants are asked to respond
periodically to different questionnaires, that describe their self-
perceived health and lifestyles in the 7 domains hypothesized
to be related to brain health. These 7 “pillars of brain health”
are overall physical/general health, nutrition, sleep, physical
activity, cognitive activity, socialization and vital plan. Moreover,
biographical and socio-demographical information, as well
as other factors related to cognitive reserve, are collected.
Furthermore, being based in the Catalan city of Barcelona,
affords the study the possibility to study the specific contribution
of bilingualism. We thus have the opportunity to study the
specific contribution of some variables related with bilingualism
(proficiency, age of acquisition, use, etc.) to cognitive reserve and
brain health (Calabria et al., 2017).
The primary end point of participation in the study is the
diagnosis of any brain (psychiatric or neurological) diseases.
Therefore, participants are asked to report new diagnosis upon
their appearance, and every year we query them for new
diagnoses and about the number of times they have visited their
GP.
A literature review of epidemiological data collected in
Catalan, Spanish, and European populations regarding major
neuropsychiatric diseases and compared with demographical
characteristics of the BBHI participants, suggested that in
10 years almost one third of our cohort will be newly diagnosed
with a neurological or psychiatric disease (see Figure 3; Von
Campenhausen et al., 2005; Bermejo-Pareja et al., 2008; Garre-
Olmo et al., 2010; Kirkbride et al., 2011; Pradas et al., 2013;
Petersen et al., 2014; Vila-Corcoles et al., 2014). Consequently,
affording us the possibility to study lifestyles and biological
determinants of brain health with sufficient signal.
2https://bbhi.cat
3https://club.bbhi.cat
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TABLE 1 | Demographic characteristics of currently enrolled participants.
Men Women
Mean (SD) Mean (SD) p-value
Age (years) 52.8 (7.3) 52.0 (7.3) <0.01∗
Men Women Total
N (%) N (%) N (%)
Participants 1414 (33.4) 2792 (66.6) 4206 (100)
Educational status
Without studies 1 (0.1) 0 1 (0.0)
Primary 60 (4.2) 116 (4.2) 176 (4.2)
Secondary 402 (28.4) 628 (22.5) 1030 (24.5)
Superiors 951 (67.3) 2048 (73.3) 2999 (71.3)
∗Univariate ANOVA comparing mean of men and women’s age.
FIGURE 2 | Example of participants’ personal profile page and web-based questionnaires.
Surveys
The initial questionnaire consists of questions pertaining to
demographic, socio-economic and anthropometric information,
as well as the presence of medical diagnosis and other health risk
factors (e.g., smoking status, alcohol consumption).
To evaluate self-perceived general health, pain, cognitive
and mental complaints we used the Patient-Reported Outcomes
Measurement Information System (PROMIS) of global health
and pain interference short forms, the Neuro-Qol cognitive
function, and the Patients health questionnaire for depression
and anxiety (Ader, 2007; Kroenke et al., 2009; Cella et al.,
2012). Living habits in nutrition, physical activity and sleep were
explored using items from the Mediterranean Diet Adherence
Scale (Schröder et al., 2010), a physical activity scale, and the
Jenkins Sleep Evaluation Questionnaire (JSEQ, Jenkins et al.,
1988) respectively. Finally, items of the Ryff scale (Ryff, 1995),
which assesses psychological well-being, are used to measure the
dimensions of “purpose in life” and “personal growth.”
In order to assess the test–retest reliability of this first
questionnaire we readministered it with a mean interval of
58 ± 3 days. 1,835 participants returned the re-administered
questionnaire. The Interclass Correlation Coefficient (ICC)
revealed a very good test-retest reliability for every sub-scale (all
r ≥ 0.80; all p < 0.01) as well as for the whole questionnaire
(r = 0.89; p < 0.01) indicating that it represents a valid
and relatively time-inexpensive instrument for multi domain
screening.
After this first questionnaire participants are asked to fill out
further validated questionnaires that probe in more detail specific
metrics associated with each of the 7 hypothesized pillars of brain
health. Launched between July and December 2017, these include
the Mediterranean Diet Adherence screener (MeDAS, Schröder
et al., 2010), the Godin–Shepard Leisure time Physical Activity
questionnaire (Godin and Shephard, 1997), the Depression,
Anxiety and Stress Scale (DASS; Brown et al., 1997), a Cognitive
Reserve Questionnaire (Rami et al., 2011), the Engaged Living
Frontiers in Aging Neuroscience | www.frontiersin.org 5 October 2018 | Volume 10 | Article 321
fnagi-10-00321 October 11, 2018 Time: 16:40 # 6
Cattaneo et al. The Barcelona Brain Health Initiative
FIGURE 3 | Graphical representation of the expected survival curve (classified
by the study’s primary end point; a diagnosis of any psychiatric or neurological
disease) of the cohort, calculated based on epidemiological and
demographical data of participants.
Scale (ELS; Trompetter et al., 2013), the Sense of Coherence
scale (SOC; Antonovsky, 1993), the Ryff scale of Psychological
well-being (Ryff, 1995), the Self Health Horizon Questionnaire
(SHH-Q; Düzel et al., 2015), the Pittsburg Sleep Quality index
(PSQI; Buysse et al., 1989) and the Lubben Social Network scale
(LSNS; Lubben, 1998).
Upon completion of the first questionnaire, a graphical
representation of the responses is provided to each participant.
The goal is to offer the participant a user friendly practical
feedback as a first step toward a ‘personal brain health index.’
The graphic is termed the ‘Healthy Habits Monitor’ (Figure 4)
and is regularly updated with the completion of additional
questionnaires that address specific aspects of the brain health.
Thus participants can see the evolution of their ‘healthy habits’
over the course of the study.
Phase II: In Person Assessment
Sub-cohort Selection Criteria
For phase II, 1,000 participants from the BBHI main cohort,
based on the information gathered in phase I have been invited to
participate. Selection criteria for phase II is based on the “Mental
Health” subscale (Hays et al., 2009) from the global health items
of the PROMIS (Ader, 2007). This sub-scale evaluates mental-
health by asking for self-perceived quality of life, social activities
and relationship, emotional and cognitive problems. Figure 5
illustrates the distribution of responses from the BBHI cohort in
this scale compared to the US general population.
In order to select participants for the second phase of the
study we calculated their scores in this sub-scale, transformed
in standardized z-score, analyzed the resulting distribution
(Figure 6), and selected, stratifying for age and sex, 500
participants from each of the two extremes of the distribution
(1,000 in total). These two extremes represent participants with
best and worst perceived mental-health of the cohort. The
rationale for these selection criteria is to afford us the greatest
possible signal to detect differences in biological correlates of
brain health by comparing those with the best and worst self-
reported brain/mental health. Indeed lower scores in these
measures have been associated in previous studies with a variety
of conditions like pain behavior, pain interference, fatigue,
anxiety, depression, physical functioning, satisfaction with
participation in social roles, and satisfaction with participation in
discretionary social activities (Rothrock et al., 2010).
Assessments
Medical and physical exam
Medical and physical examination procedures were approved
by the institution review board of the Institut Guttmann. Upon
singing informed consent the participants undergo a medical
evaluation and screening. This exam gathers medical personal
and family history, social history, educational history, review
of systems, and includes a medical exam, a cardiopulmonary
exercise test (CPET), an evaluation of gait and balance, and
a dual task performance test (Manor et al., 2016, 2018).
Biological samples, initially focusing on blood and stool,
are collected for laboratory tests and the determinations of
biomarkers. Further blood samples are stored for genetic
and epigenetic determinations. Biochemical, proteomics and
metabolomic profiling will be carried out in plasma samples.
Cognitive assessment
The neuropsychological assessment comprises both paper and
pencil, and computerized tests, administered in two separate
sessions.
Paper and pencil assessment consists of a battery of well-
established neuropsychological tests, exploring the different
cognitive functions, while the computerized cognitive assessment
includes four task used in the Cognition, Brain, and Aging study
(COBRA; Nevalainen et al., 2015) evaluating processing speed
and working memory.
The paper and pencil neuropsychological assessments evaluate
general/fluid intelligence (WAIS-IV Matrices, Weschler, 2008),
premorbid intelligence (National Adult Reading Test; Nelson
and Willison, 1991) vocabulary (semantic verbal fluency, Peña-
Casanova, 2005), selective attention (Cancelation test WAIS-
IV; Weschler, 2008), executive functions (Trial making test
B, phonemic verbal fluency; Reitan and Wolfson, 1985; Peña-
Casanova, 2005) and working memory (Digit backward, Letter
number sequencing), episodic memory (RAVLT; Rey, 1958),
processing speed (digit symbol substitution; Weschler, 2008),
motor and visuo-motor speed (finger-tapping, TMT-A; Reitan
and Wolfson, 1985; Shimoyama et al., 1990), visuo-spatial
abilities (Block design; Weschler, 2008).
Magnetic Resonance Imaging
Magnetic Resonance Imaging (MRI) data acquisition is
undertaken using a 3 Tesla Siemens PRISMA scanner and a
32-channel head coil.
The MRI session lasts approximately 1 h and includes
accelerated multiband sequences adapted from the Human
Connectome Project (D) and provided by the Center of Magnetic
Resonance Research (CMRR) at the University of Minnesota.
The protocol includes several high resolution structural T1-,
T2-weighted and a FLAIR scans, which will allow us to
quantify longitudinal changes in cortical and subcortical volume,
myelination, white matter integrity and vascular disease.
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FIGURE 4 | An illustration of the graphical feedback (‘Healthy Habits Monitor’) of an individual participant’s responses to questionnaires regarding the 7 hypothesized
pillars of brain health.
FIGURE 5 | Graphical representation of participant’s T-scores distribution in the Mental Health sub-questionnaire, and comparison with US population. An
independent samples t-test showed that the scores in the Mental Health index of all BBHI participants (N = 4206; mean = 49.8; SD = 6.9) do not differ significantly
from reference scores of the general US population (values taken from PROMIS Global health scoring Manual: mean = 50; SD = 10; t = 1.7, p = 0.10).
High-resolution multishell diffusion-weighted MRI
(1.5 mm × 1.5 mm × 1.5 mm, 100 directions) is obtained
to further characterize tissue integrity in white matter, where the
anisotropy of water diffusion is known to capture the geometry
and state of myelin sheaths along axonal tracts, but also within
the cortex.
High resolution resting state functional MRI (fMRI)
(2 mm × 2 mm × 2 mm and TR = 0.8 s) is acquired to study
lifespan longitudinal changes in both whole-brain functional
networks and patterns of local cortico-cortical coupling.
A second fMRI scan is acquired during a working memory
and memory encoding tasks. To this end, two subgroups are
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FIGURE 6 | Graphical representation of participant’s z-scores distribution in the Mental health sub-questionnaire. The red circles marks the two selection groups at
the two extremes of the distribution.
randomly selected out of our Phase-II sample, each assigned to
one memory task to avoid overloading the MRI protocol.
Finally, an advanced high resolution pseudo-Continuous
Arterial Spin Labeling (pCASL) sequence is acquired to identify
small focal lesions and quantify cerebral blood flow (CBF) and
arterial transit time (ATT) in cortical and subcortical structures.
The brain anatomical MRI’s are reviewed with a
neuroradiologist in order to generate a first report that might
identify actionable findings and offer some return of results to
participants.
Electroencephalography (EEG)
Thirty two channel EEG is acquired using the Enobio 32-channel
EEG cap from Neuroelectrics (Barcelona, Spain) during rest (eyes
open and eyes closed) and during the performance of an auditory
Oddball task and a Flanker task. These tasks are used to collect
event-related potentials (ERPs) to assess the neurophysiological
response to conflict resolution monitoring and signal detection.
Some changes in ERPs’ components elicited by these tasks,
e.g., the P300 in the Oddball tasks, have been found to relate
with information processing and age-related cognitive decline
(see van Dinteren et al., 2014 for a meta-analysis). In addition,
further electrophysiological EEG substrates are collected and
analyzed such as frequency analysis oscillatory power bands and
coherence, an index of the synchrony between cortical regions.
Neuroelectrics Instrument Controller software is used for
initial EEG analysis in order to generate a first report that might
identify actionable findings and offer some return of results to
participants.
Transcranical Magnetic Stimulation and EEG
Transcranial magnetic stimulation combined with EEG allows
the characterization of cortical excitability and reactivity
(Pascual-Leone et al., 2011; Shafi et al., 2014; Farzan et al.,
2016). Single pulse and paired pulse TMS using a Medtronic
MagPro X100 stimulator, combined with high density TMS
compatible EEG system (BrainProducts Brain ActiChamp,
Gilching, Germany), are applied over 5 stimulation sites: primary
motor cortex (M1), left and right inferior parietal lobule, and left
and right lateral dorsolateral prefrontal cortex. These target areas
are defined based each individual’s brain MRI and targeted using
frameless stereotaxy. The targeting of these latter regions is based
on the fact that they comprise nodes of two brain networks highly
sensitive to the effects of aging, namely the fronto-parietal and the
default mode network (DMN, Andrews-Hanna et al., 2007; Sala-
Llonch et al., 2015; Damoiseaux, 2017), which is also critically
affected in early stages of AD (Sheline and Raichle, 2013). Motor
evoked potentials (measured via electromyography at the hand
muscle) from M1 stimulation and TMS-evoked potentials (TEPs)
are recorded from non-motor regions.
Participants Feedback and Incidental Findings Report
Once finished the in-person assessment an initial review
of results is done by expert personal and supervised by a
physician in order to identify actionable and incidental findings.
Additionally, a brief report is developed that is subsequently
sent to the participant with an explanation of which tests were
performed, the result, and a brief overview of the significance
of each test. Participants are informed about the lack of
clinical value of this report and that this assessment does
not substitute any medical or clinical assessment planned or
previously done. Incidental medical findings are evaluated by
the designated physician and communicated to participants as
soon as an abnormality is detected during the assessments.
Expert staff will be consulted as needed to assist with the
interpretation of the results and the recommendations for
follow-up (e.g., radiologist, neurologist/neurosurgery specialist,
cardiologist, sleep physician,...). If it is determined that the
participant would benefit from medical follow-up, he or she will
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be instructed to contact their general practitioner who will be
provided with a report of the relevant findings. If there is concern
for the participant’s immediate health, they will be referred to
emergency medical care as needed.
Phase III: Randomized Control Trial of a
Multi-Dimensional Lifestyle Intervention
The third phase of the study is aimed to start in 2019 and
will consist of a 6-month multi-dimensional intervention,
administered via an Information and Communication
Technology (ICT)-based platform. Five hundred participants
from the general cohort who did not participate in phase II
will be invited to participate. Phase III will be a randomized-
control trial (RCT) of a multidomain intervention of remotely
supervised coach-led lifestyle habits. A control group will consist
of participants who receive education regarding healthy lifestyles
but no coaching. All participants will undergo the in-person
evaluations described in phase II at baseline and following the
6-month intervention. All participants will be monitored using
mobile technologies to assess adherence to the multi-dimensional
intervention and capture relevant metrics of physical activity,
diet, sleep, etc.
Multi-Dimensional Intervention: Rationale and
Characteristics
The multi-dimensional intervention will include cognitive
training, physical exercise, adherence to the Mediterranean
diet, maintenance of social activities, healthy sleep habits, and
participation in mindfulness sessions. Several recent reviews
and meta-analyses have demonstrated the weaknesses and
inconsistencies of single physical, nutritional, or cognitive
interventions (Brasure et al., 2018; Butler et al., 2018a,b) for
the promotion of cognitive fitness and brain health. Indeed,
the multi-factorial etiology of neurodegenerative diseases may
necessitate the use of multi-domain interventions (Mangialasche
et al., 2012). Accordingly, the need to evaluate the effects
of multi-dimensional interventions is present (Kivipelto et al.,
2013; Vellas et al., 2014; Kulmala et al., 2018) and a number
of recent studies have assessed their effects. The Finnish
Geriatric Intervention Study to Prevent Cognitive Impairment
and Disability (FINGER; Kivipelto et al., 2013; Kivipelto et al.,
2018) explored the effects of a multi-dimensional intervention
composed of cognitive training, physical exercise, diet and
monitoring of cardiovascular risk factors in preventing cognitive
decline in at risk people as measured by the Cardiovascular
Risk Factors, Aging, and Incidence of Dementia (CAIDE) score.
After a 2-year intervention results showed a small benefit of the
intervention in global cognitive functioning (Ngandu et al., 2015;
Rosenberg et al., 2018).
Following the same logic Vellas et al. (2014) assessed in the
Multidomain Alzheimer Prevention Trial (MAPT) the efficacy
of: (1) a single domain supplementation with omega-3 fatty
acid; (2) a multi-dimensional intervention including nutritional
counseling, physical exercise and cognitive stimulation; or (3) a
combination of the two. Initial data showed no significant effects
of any of the interventions on cognitive decline over 3 years
(Andrieu et al., 2017). However, a secondary analysis of the
data narrowed to high-risk people using similar criteria of the
FINGER study (i.e., CAIDE ≥ 6) found benefit of the multi-
domain intervention in some cognitive outcomes (Chhetri et al.,
2018).
Two important lessons can be derived from these results.
Firstly, they highlight the importance of early interventions to
prevent cognitive decline. That is, as previously mentioned (see
Introduction), changes in the brain begin decades prior to the
onset of symptoms and consequently, lifestyle interventions may
be necessary across the whole lifespan, long before these changes
commence.
Second, a large number of sensitive baseline measures are
fundamental to detect true effects of lifestyle interventions on
cognitive decline and prevention of neurodegenerative diseases,
and fully explain and understand the different age-related
trajectories (Nilsson and Lövdén, 2018).
Phase III of the BBHI aims to fill these gaps in knowledge
through a multi-domain lifestyle intervention, during mid-life
with a large number of baseline and post-intervention metrics
sensitive to differences in brain health. Prior to launching, this
third phase of the BBHI will be registered in clinicaltrials.gov.
All the intervention will be ICT-based, designing and
developing a solution consisting on two main parts: (1) a mobile
application (the BBHI app) that participants will download; and
(2) a web-based portal for coaches. The BBHI app will allow
us to administer, coach and monitor the different domains of
the intervention program. Users will have access to the different
modules (addressing the defined 7 brain health pillars) and the
web-based portal will allow coaches managing and tracking their
performances in these different domains. This ad hoc ICT-based
developed solution will allow us to have all monitored data stored
in our Data Warehouse, structured and ready for analysis.
At the time of writing the exact details of the Phase III
protocol are under discussion with the International Scientific
Advisory Board Members of the study. Consequently, the exact
protocols for each intervention will be guided by the most up
to date literature on each topic at the time of the phase launch.
Notwithstanding, there is consensus regarding the general lines
of the intervention, which will include the following modalities;
Cognitive training, administered by the BBHI app, will be
developed in-house based on previous successful intervention
studies (Schmiedek et al., 2010; Schweizer et al., 2011; Wolinsky
et al., 2011; Sandberg et al., 2014). It includes tasks that engage
different cognitive domains as attention (e.g., visual search),
speed of processing (e.g., perceptual speed task), set shifting (e.g.,
task switching), inhibition (e.g., Stroop task), working memory
(e.g., dual n-back task), reasoning (e.g., sequencing task) and
memory (visual span and recent probe task). As the majority of
cognitive training studies we will use a multi-domain approach,
that have often reported better effects over-time than single-
domain cognitive training (Cheng et al., 2012; Lampit et al.,
2014).
Physical exercise, monitored by the BBHI app and wrist-
based heart rate technology. A recent systematic review has shed
light on the optimal dosages for consistent exercise-mediated
improvements in aging (Gomes-Osman et al., 2018). In line with
this approach the exact frequency, intensity and type of our
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exercise intervention will be determined by the extant literature
at the time of phase launch.
Nutrition, where participants will be asked to follow a typical
Mediterranean diet (Lourida et al., 2013), and their adherence
to this dietary prescription will be assessed periodically by a
questionnaire (Schröder et al., 2010) administered via BBHI app.
Healthy sleep habits, which will be guided by
recommendations from Global Council for Brain Health4
and monitored by the BBHI app.
Finally, participants will be asked to participate in group
sessions directed to help them to focus on what is important for
them and live a values oriented life, using technique that include
meditation and mindfulness (Franquesa et al., 2017).
Coaching and Monitoring
Monitoring and control of participant adherence to a multi-
dimensional intervention has been highlighted as a fundamental
methodological issue faced in previous studies (Kivipelto et al.,
2013; Vellas et al., 2014). Numerous recent studies evaluating
health coaching programs stress the relevance of monitoring
and coaching (Dejonghe et al., 2017) to increase participant
motivation and adherence (Barbera et al., 2018). Nevertheless,
there is still a research gap in regard to feasibility, scalability, and
long-term effectiveness.
Although health coaching can be seen as an interpersonal
process, where communication and relation between the coach
and the user are central aspects, ICT-based solutions offer
very interesting opportunities, in both measurement as well
as intervention (Rutjes et al., 2017; Barbera et al., 2018). One
of the main advantages of coaching programs supported by
technology is the possibility of seamlessly measuring behavioral
data, thanks to devices and wearables which provide objective
data about performance. Thanks to the potential of large datasets
to provide learning opportunities via the implementation of
artificial intelligent processes, the prediction of the effectiveness
of each intervention can be calculated.
In our proposal, each coach will be responsible for the
individualization and follow-up of the multi-dimensional activity
programs. This will be implemented remotely with the use of
ICT technologies (Simkin-Silverman et al., 2011; Barbera et al.,
2018) and based on the SMART Goals (Bovend’Eerdt et al., 2009),
Reinforcement Theory of Motivation (Cameron and Pierce,
1994) and Social Comparison (Festinger, 1954) theories.
Data Managing
BBHI is an ICT-based study, where technology plays a key role in
the collection and management of the data. The data generated
via online questionnaires is transferred using secure procedures
and stored in a cloud server, which assures full-time access
to data as well as the necessary security protocols. Encrypted
communication based on TLS (Transport Layer Security) is
used whenever personal information is transferred between
systems. The collected data are anonymized and kept confidential
to protect the privacy of the participating users, fulfilling all
4https://www.aarp.org
the requirements stated by the Spanish Organic Law and EU
regulations.
ANTICIPATED RESULTS
Limits of Detection and Statistical
Analysis
Phases I and II
Considering the sample size of participants in phase I we
calculated the relative risk of being exposed to a “brain health
related” factor (or combination of factors) by comparing
the estimated incidence rate of any neurological and
neuropsychiatric diseases predicted in the Catalan population
and the incidence predicted in a certain % of the cohort exposed
to a protective factor (see Dartigues et al., 1992; Cyceron, 2003).
Assuming α risk of 0.05, a β risk of 20%, and a 5% per year drop
out, after 5 years we will be able to identify a protective factor that
represents a relative risk of 0.77, if 30% of participants are exposed
to it. If the number of participants exposed is 20% the minimum
relative risk identifiable is 0.73 and for an amount of 10% it is
0.66.
For the in person assessment (phase II), where 1,000
volunteers will be examined in-person, we will be able to detect
a 0.61 relative risk if 30% of participants are exposed, 0.55 relative
risk for 20% exposed, and 0.44 relative risk for 10% exposed.
Based on evidence from previous studies that look at the
association between the reduction in the incidence of various
neurological and neuropsychiatric diseases and different lifestyles
these results indicate that at 5 years we will have sufficient power
to detect factors related with brain health maintenance in our
sample (La Rue, 2010; Baglioni et al., 2011; Kuiper et al., 2015;
Frankish and Horton, 2017). Note however, that the main goal of
the phase II of BBHI is descriptive, aiming for a deep phenotyping
characterization of the biological markers of brain health.
Effects of Intervention in Phase III
A recent meta-analysis (Zhu et al., 2016) proposed that
the estimated combined effect size of physical and cognitive
interventions, presented as Cohen’s d, is 0.29. In our study,
considering α = 0.05, a β = 10 and an annual drop-out of 5%, we
will be able to detect in a pre-post repeated measure ANOVA on
the different outcomes (e.g., Flanker effect) between two groups
of 250 participants a small effect d = 0.17.
Principal Statistical Analysis
Principal statistical analyses to be performed will include mainly
linear regression models in within-subjects and between-groups
experimental designs. We may require applying non-parametric
statistics in certain cases.
We will also use exploratory data mining techniques like
clustering and classifiers in order to identify groups of similar
participants and explore the relation between different biologic
and lifestyles variables and the different outcomes.
The final aim of this study is to investigate and identify those
factors that can promote Brain Health. Considering the binary
nature of the end-point of this study (phase I and II), the analysis
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within the study population will be based on the calculation
of odds ratios, hazard ratios and relative risks of exposure to
protective factors on the a priori-defined 7 pillars of interest. All
analyses will be performed correcting for covariate variables (e.g.,
age, sex, education, income, etc.)
Pitfalls, Artifacts and Troubleshooting
This study presents various pitfalls and limitations. Similar to
all long-term longitudinal studies, participant drop-out is a
crucial pitfall that needs to be addressed. In order to minimize
participant drop-out we aim to keep participants engaged
via strategies described previously (see “BBHI Launching and
Recruiting” and “The BBHI Community”). Briefly, we maintain
regular communication with participants via social media,
periodic public conferences, dissemination of information on
recent findings, organization of public events, as well as
periodically inviting participants to face to face meetings with the
BBHI research and leadership team.
Given the longitudinal nature of the study, another possible
pitfall is the possibility for variability in data collection due to
instructor bias. To minimize this risk detailed protocols and
extensive training is performed by each new member of the
research team. Additionally, periodic data quality checks are
performed to ensure the quality and reproducibility of the data
being collected.
Lastly, as discussed in Section “Characterization of the
Cohort,” our cohort is currently not fully representative of the
general population for gender (over-representation of women)
and educational status (higher than general population). We aim
to correct this through ongoing, targeted participant recruitment.
Nevertheless, these biases will be considered when analyzing and
interpreting and the data.
CONCLUSION
The BBHI is a large longitudinal cohort study being conducted
in Spain, focused on the promotion of brain health in
middle aged adults. The study’s aims are to investigate the
biological, environmental and social determinants of brain health
maintenance, and whether a multi-dimensional intervention
program, focused on life-style habit changes, can have short
and long terms effects on cognitive functioning and reduces the
incidence of neuropsychiatric brain diseases.
The BBHI will allow us to combine the findings from
both a prospective cohort analysis and a randomized-controlled
intervention, conducted with the same harmonized measures
and outcomes. In line with recent biosocial models of network
medicine (Greene and Loscalzo, 2017), the three phases of the
BBHI with relate biologic evidence with environmental and
social analyses, and enable a deeper understanding of factors
promoting healthy aging. Beyond a holistic elucidation of health
and disease in aging, the BBHI will investigate if an individualized
multi-dimensional intervention program can enhance cognitive
functions and reduce the incidence of new future diagnoses.
Given the complex interactions of the determinants of individual
pathophenotypes (Kivipelto et al., 2013), multi-dimensional
interventions and their interactions may yield the best response.
The broad and favorable response to the BBHI, with fast
recruitment and high retention rates of a very active cohort,
reflects the interest and timeliness of the topic of brain health.
Female (66%) and higher-educated (70%) persons are overly
represented in the BBHI cohort. This, however, is in line with
other longitudinal studies ongoing in Spain (Olazarán et al.,
2015). The over-representation of these demographics, possibly
reflects the advanced literacy required to complete the surveys
(Olazarán et al., 2015) or the increased education on brain health
among more educated individuals. Indeed, gender differences in
the utilization of health care suggest that women tend to use
diagnostic and preventative medicine more than men (Gómez
Gómez, 2002).
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